IDYA
Ideaya Biosciences Inc
NASDAQ: IDYA · HEALTHCARE · BIOTECHNOLOGY
$28.05
-3.41% today
Updated 2026-04-29
Market cap
$2.46B
P/E ratio
—
P/S ratio
11.26x
EPS (TTM)
$-1.28
Dividend yield
—
52W range
$17 – $39
Volume
1.3M
Ideaya Biosciences Inc (IDYA) Financial statements
SEC filings — annual and quarterly data.
Profit margin
-52.00%
Operating margin
-870.00%
ROE
-10.90%
ROA
-8.92%
Debt/equity
0.05x
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2017 | $0.00 | $-11.86M | — | — | — |
| 2018 | $0.00 | $-34.35M | — | — | — |
| 2019 | $0.00 | $-38.44M | — | — | — |
| 2020 | $19.54M | $-32.27M | 100.00% | -180.90% | -165.14% |
| 2021 | $27.94M | $-47.53M | 100.00% | -179.91% | -170.11% |
| 2022 | $50.93M | $-54.81M | 100.00% | -122.72% | -107.61% |
| 2023 | $23.39M | $-112.96M | 82.86% | -574.85% | -483.05% |
| 2024 | $7.00M | $-274.48M | 45.23% | -4,671.07% | -3,921.10% |
| 2025 | $218.71M | $-113.70M | 97.90% | -72.84% | -51.99% |